Antibody development after three mRNA SARS-CoV-2 vaccinations in patients with systemic autoimmune rheumatic disease with and without treatment: an observational cohort study

Objectives and design To further elucidate the effects of rare systemic autoimmune rheumatic diseases (SARD) and their treatment on antibody development after vaccination against SARS-CoV-2, we compared patients with and without immunosuppressive therapy to healthy controls in an observational cohor...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Daniel Aletaha, Peter Mandl, Helmuth Haslacher, Thomas Perkmann, Stefan Winkler, Selma Tobudic, Thomas Deimel, Thomas Karonitsch, Stephan Blueml, Felix Kartnig, Daniel Mrak, Elisabeth Simader, Gregor Mitter
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMJ Publishing Group 2025-09-01
Schriftenreihe:	BMJ Open
Online-Zugang:	https://bmjopen.bmj.com/content/15/9/e094948.full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!